| |
| |
|
| Insider
Information: |
Calvin Sandra |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
52,017 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$329,788 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
52,017 |
|
|
| Total
Value |
$329,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Travere Therapeutics, Inc |
TVTX |
|
2024-02-01 |
52,017 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TVTX |
Travere Therapeutics, Inc |
SVP, CHIEF ACCOUNTING OFFICER |
• – – |
2024-02-01 |
4 |
S |
$8.53 |
$24,058 |
D/D |
(2,820) |
52,017 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, CHIEF ACCOUNTING OFFICER |
• – – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,500 |
54,837 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, CHIEF ACCOUNTING OFFICER |
• – – |
2024-01-23 |
4 |
S |
$9.07 |
$8,252 |
D/D |
(910) |
41,337 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, Chief Accounting Officer |
• – – |
2023-05-11 |
4 |
AS |
$16.12 |
$1,967 |
D/D |
(122) |
42,247 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, Chief Accounting Officer |
• – – |
2023-05-10 |
4 |
AS |
$16.59 |
$7,233 |
D/D |
(436) |
42,369 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, Chief Accounting Officer |
• – – |
2023-02-02 |
4 |
AS |
$22.42 |
$8,071 |
D/D |
(360) |
42,805 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, Chief Accounting Officer |
• – – |
2023-02-01 |
4 |
AS |
$21.75 |
$36,348 |
D/D |
(1,671) |
43,165 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, Chief Accounting Officer |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
44,836 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, Chief Accounting Officer |
• – – |
2023-01-25 |
4 |
AS |
$21.63 |
$4,153 |
D/D |
(192) |
34,836 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, Chief Accounting Officer |
• – – |
2023-01-24 |
4 |
AS |
$21.90 |
$19,823 |
D/D |
(905) |
35,028 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, Chief Accounting Officer |
• – – |
2022-09-13 |
4 |
S |
$28.00 |
$9,772 |
D/D |
(349) |
35,933 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, Chief Accounting Officer |
• – – |
2022-05-11 |
4 |
S |
$21.92 |
$9,756 |
D/D |
(445) |
35,733 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, Chief Accounting Officer |
• – – |
2022-05-10 |
4 |
S |
$21.51 |
$9,378 |
D/D |
(436) |
36,178 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
VP, Corp Controller and CAO |
• – – |
2022-01-31 |
4 |
S |
$26.51 |
$21,152 |
D/D |
(798) |
36,614 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
VP, Corp Controller and CAO |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
37,412 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
VP, Corp Controller and CAO |
• – – |
2022-01-24 |
4 |
S |
$24.58 |
$22,955 |
D/D |
(934) |
28,662 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
VP, Corp Controller and CAOOff |
• – – |
2021-09-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,754 |
|
% |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
